Treatment strategies for co-occurring ADHD and substance use disorders

被引:107
作者
Mariani, John J.
Levin, Frances R.
机构
[1] Columbia Univ Coll Phys & Surg, New York State Psychiat Inst, New York, NY 10032 USA
[2] Columbia Univ, Coll Phys & Surg, Div Substance Abuse, New York, NY USA
关键词
ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT HYPERACTIVITY DISORDER; NATIONAL-COMORBIDITY-SURVEY; COCAINE-DEPENDENT PATIENTS; MULTIMODAL PSYCHOSOCIAL TREATMENT; LONG-TERM METHYLPHENIDATE; PLACEBO-CONTROLLED TRIAL; FILM-COATED TABLETS; DOUBLE-BLIND; SURVEY REPLICATION;
D O I
10.1080/10550490601082783
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Attention-deficit hyperactivity disorder (ADHD) is a common co-occurring mental disorder among patients with substance use disorders (SUD). Clinicians must be cognizant of the complicated nature of diagnosis and treatment of ADHD when comorbid with SUD. Pharmacotherapy remains the mainstay of treatment for ADHD, although complementary psychotherapeutic approaches have been developed. Psychostimulant medications are the most commonly used medications to treat ADHD, but many clinicians are reluctant to prescribe stimulants to patients with SUD. Recommendations for treatment planning and clinical management for patients with co-occurring ADHD and SUD are discussed.
引用
收藏
页码:45 / 56
页数:12
相关论文
共 106 条
  • [81] Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration
    Solanto, MV
    [J]. BEHAVIOURAL BRAIN RESEARCH, 1998, 94 (01) : 127 - 152
  • [82] An open-label pilot study of methylphenidate in the treatment of cocaine dependent patients with adult attention deficit/hyperactivity disorder
    Somoza, EC
    Winhusen, TM
    Bridge, TP
    Rotrosen, JP
    Vanderburg, DG
    Harrer, JM
    Mezinskis, JP
    Montgomery, MA
    Ciraulo, DA
    Wulsin, LR
    Barrett, JA
    [J]. JOURNAL OF ADDICTIVE DISEASES, 2004, 23 (01) : 77 - 92
  • [83] Sparrow, 1999, J ATTEN DISORD, V3, P141, DOI [10.1177/108705479900300303, DOI 10.1177/108705479900300303]
  • [84] Efficacy of a mixed amphetamine salts compound in adults with attention-deficit/hyperactivity disorder
    Spencer, T
    Biederman, J
    Wilens, T
    Faraone, S
    Prince, J
    Gerard, K
    Doyle, R
    Parekh, A
    Kagan, J
    Bearman, SK
    [J]. ARCHIVES OF GENERAL PSYCHIATRY, 2001, 58 (08) : 775 - 782
  • [85] PET study examining pharmacokinetics, detection and likeability, and dopamine transporter receptor occupancy of short- and long-acting oral methylphenidate
    Spencer, TJ
    Biederman, J
    Ciccone, PE
    Madras, BK
    Dougherty, DD
    Bonab, AA
    Livni, E
    Parasrampuria, DA
    Fischman, AJ
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2006, 163 (03) : 387 - 395
  • [86] A cognitive remediation programme for adults with Attention Deficit Hyperactivity Disorder
    Stevenson, CS
    Whitmont, S
    Bornholt, L
    Livesey, D
    Stevenson, RJ
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2002, 36 (05) : 610 - 616
  • [87] Reinforcing, subject-rated performance and physiological effects of methylphenidate and d-amphetamine in stimulant abusing humans
    Stoops, WW
    Glaser, PEA
    Fillmore, MT
    Rush, CR
    [J]. JOURNAL OF PSYCHOPHARMACOLOGY, 2004, 18 (04) : 534 - 543
  • [88] Substance Abuse and Mental Health Services Administration, 2003, DHHS PUBL
  • [89] Swanson J, 1994, SNAP 4 SCALE
  • [90] Modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: Results of a randomized, double-blind, placebo-controlled, fixed-dose study followed by abrupt discontinuation
    Swanson, JM
    Greenhill, LL
    Lopez, FA
    Sedillo, A
    Earl, CQ
    Jiang, JG
    Biederman, J
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2006, 67 (01) : 137 - 147